Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Cabibbo, Giuseppe ^a   Maida, Marcello ^a   Genco, Chiara ^a   Alessi, Nicola ^a   Peralta, Marco ^a   Butera, Giuseppe ^a   Galia, Massimo ^a   Brancatelli, Giuseppe ^a   Genova, Claudio ^a   Raineri, Maurizio ^a   Orlando, Emanuele ^a   Attardo, Simona ^a   Giarratano, Antonino ^a   Midiri, Massimo ^a   Di Marco, Vito ^a   Craxì, Antonio ^a   Cammà, Calogero ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BURN; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EARLY CANCER; FEMALE; FEVER; FOLLOW UP; HEPATITIS B; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMATOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR SEEDING; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FIBROSIS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84880841857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070016     Document Type: Article

References (27)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 14 334(11): 693-9.
2. European Association For The Study Of The Liver, European Organisation For Research, Treatment Of Cancer, (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 56(4): 908-43.
3. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, et al. (2008) Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 21 100(10): 698-711.
4. Künzli BM, Abitabile P, Maurer CA, (2011) Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. World J Hepatol. 27 3(1): 8-14.
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 35(3): 421-30.
6. Bruix J, Sherman M, (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology. 42(5): 1208-36.
7. Llovet JM, Brù C, Bruix J, (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 19(3): 329-38.
8. Lencioni R, Llovet JM, (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 30(1): 52-60.
9. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, et al. (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 51(4): 1274-83.
10. Cammà C, Cabibbo G, (2009) Prognostic scores for hepatocellular carcinoma: none is the winner. Liver Int. 29(4): 478-80.
11. Cabibbo G, Craxì A, (2009) Hepatocellular cancer: optimal strategies for screening and surveillance. Dig Dis. 27(2): 142-7.
12. Piscaglia F, Leoni S, Cabibbo G, Borghi A, Imbriaco G, et al. (2010) Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. Dig Liver Dis. 42(10): 729-34.
13. Licata A, Nebbia ME, Cabibbo G, Iacono GL, Barbaria F, et al. (2009) Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol. 15(17): 2132-8.
14. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 47(1): 82-9.
15. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M, (2009) Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 104(2): 514-24.
16. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, et al. (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 40(6): 1352-60.
17. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, et al. (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 53(1): 136-47.
18. Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, et al. (2011) Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther. 34(2): 196-204.
19. Maida M, Cabibbo G, Brancatelli G, Genco C, Alessi N, et al. (2013) Assessment of treatment response in hepatocellular carcinoma: a review of literature. Future Oncol. 9(6): 845-854.
20. Villanueva A, Llovet JM, (2012) Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma. Hepatology. 56(6): 2416-9.
21. Villanueva A, Hoshida Y, Llovet JM, (2011) Hepatocellular carcinoma enters the sequencing era. Gastroenterology. 141(5): 1943-5.
22. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, et al. (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 240(5): 900-9.
23. Vitale A, Morales RR, Zanus G, Farinati F, Burra P, et al. (2011) Italian Liver Cancer group. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol. 12(7): 654-62.
24. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 243(3): 321-8.
25. Cabibbo G, Latteri F, Antonucci M, Craxì A, (2009) Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol. 6(3): 159-69.
26. Genco C, Cabibbo G, Maida M, Brancatelli G, Galia M, et al. (2013) Treatment of hepatocellular carcinoma: present and future. Expert Rev Anticancer Ther. 13(4): 469-79.
27. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, et al. (2013) Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial. J Clin Oncol. 31(4): 426-32.